INVASCENT ILSF MANAGER LLP
INVASCENT ILSF MANAGER LLP is a Series C+ and buyout fund in India writing $10M–$40M checks into healthcare-tech, pharmaceuticals, animal-health, medical-devices and specialty-ingredients.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech, pharmaceuticals, animal-health, medical-devices, specialty-ingredients
- Check size
- $10M–$40M
- Invests in
- India
- Actively investing
- Yes
- Founded
- 2005
- Assets under management
- $800M-$850M
Thesis
InvAscent is an Indian private equity firm founded in 2005, specializing in the life sciences sector. The firm focuses on providing growth capital and strategic guidance to small and mid-sized Indian companies across pharmaceuticals, healthcare delivery, medical devices, animal health, specialty ingredients, and healthtech. Their investment thesis centers on nurturing market leaders within the Indian life sciences ecosystem, employing a collaborative partnership model. InvAscent's geographic scope is primarily India, and their strategy includes growth equity and buyouts/LBOs. They manage between $800 million and $850 million in AUM. For their India Life Sciences Fund III, the typical check size ranged from $10 million to $40 million.
Common questions
Does INVASCENT ILSF MANAGER LLP invest at the Series C+ stage?
Yes. INVASCENT ILSF MANAGER LLP lists Series C+ and buyout among the stages it invests in.
What check size does INVASCENT ILSF MANAGER LLP write?
INVASCENT ILSF MANAGER LLP writes $10M–$40M checks.
Where does INVASCENT ILSF MANAGER LLP invest?
INVASCENT ILSF MANAGER LLP invests in India.